feed,title,long_url,short_url
Benzinga,GSK Limits Second-Line Maintenance Use Of Its Ovarian Cancer Drug To Some Populations,https://benzinga.com/general/biotech/22/11/29680261/gsk-limits-second-line-maintenance-use-of-its-ovarian-cancer-drug-to-some-populations,https://bit.ly/3hBaBCU
